GlassScriptPhysician profile
Michael S Williams
NPI 1750544011
$4,664.55
in general payments reported to CMS, 2019-2025
30 companies · $628 in 2025
The $628 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,188 · 2020: $939 · 2021: $343 · 2022: $1,218 · 2023: $202 · 2024: $148 · 2025: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $934 · Travel and Lodging: $43.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $933.83 |
| Travel and Lodging | $43.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $1,026.70 | 2020-2022 | |
| Penumbra, INC. | $687.14 | 2019-2025 | Indigo System, Penumbra System |
| W. L. Gore & Associates, INC. | $511.58 | 2019-2023 | Gore Excluder Iliac Branch Endoprosthesis |
| Bard Peripheral Vascular, INC. | $389.68 | 2019-2020 | |
| Abbott Laboratories | $264.33 | 2019-2021 | |
| Acell, INC. | $215.47 | 2019-2020 | |
| Calyxo, INC. | $140.05 | 2025 | Cvac Aspiration System |
| Inari Medical, INC. | $137.84 | 2020 | |
| Baxter Healthcare | $124.43 | 2019 | |
| Silk Road Medical, INC. | $120.73 | 2020 | |
| Kerecis Limited | $108.03 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Ethicon US, LLC | $104.34 | 2020 | |
| Getinge USA Sales, LLC | $100.99 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $87.50 | 2020 | |
| Davol INC. | $82.36 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $79.47 | 2019 | |
| Kci USA, INC. | $78.09 | 2019 | |
| Bolton Medical INC | $63.13 | 2021 | |
| Cook Medical LLC | $62.58 | 2021 | |
| Idorsia Pharmaceuticals US INC | $60.63 | 2024 | Quviviq |
| Misonix INC | $51.01 | 2019 | |
| Angiodynamics, INC. | $40.71 | 2019-2022 | |
| Shape Memory Medical INC. | $32.72 | 2025 | Impede Embolization Plug |
| Sanara Medtech INC. | $20.90 | 2021 | |
| Ucb, INC. | $20.76 | 2024 | Cimzia |
| Noven Therapeutics, LLC | $15.00 | 2023 | Secuado |
| Astrazeneca Pharmaceuticals LP | $14.14 | 2024 | Andexxa |
| Allergan, INC. | $12.68 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.56 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.